Vicore Pharma

Showing 2 posts of 2 posts found.

Vicore announces initiation of proof-of-concept study for endothelial dysfunction treatments

May 4, 2023
Research and Development Cardiology, Vicore Pharma, clinical trials, endothelial dysfunction, organ damage

Vicore Pharma Holding AB has announced that it has dosed the first patient with C21 in its randomised, double-blind, placebo-controlled, …

Vicore Pharma study suggests C21 could complement COVID-19 vaccines

December 23, 2020
Research and Development COVID-19, Vicore Pharma

Vicore Pharma, a Swedish company focused on developing medicines for severe lung disorders, has published data suggesting that its oral …

Latest content